Skip to main content
Top
Published in: Infectious Diseases and Therapy 1/2015

Open Access 01-09-2015 | Original Research

Impact of Antimicrobial Stewardship Program (ASP) on Outcomes in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in an Acute-Tertiary Care Hospital

Authors: Li Wen Loo, Yi Xin Liew, Winnie Lee, Piotr Chlebicki, Andrea Lay-Hoon Kwa

Published in: Infectious Diseases and Therapy | Special Issue 1/2015

Login to get access

Abstract

Introduction

Acute bacterial skin and skin structure infections (ABSSSIs) are among the most common infections treated in hospitals, but to date, there has been little information with regards to the implementation of Antimicrobial Stewardship Programs (ASPs) for patients with ABSSSIs. Hence, we aim to evaluate the impact of ASPs on the following outcomes in patients with ABSSSIs: duration of therapy and hospital stay, 14-day reinfection, infection-related readmissions and mortality.

Methods

A retrospective review of the ASP database was conducted, focusing on selected outcomes (as above) among all patients in whom the institution’s ASP recommended a change in antibiotic regimen—de-escalation of the antibiotic based on culture results; discontinuation of the antibiotic; narrowing of the empirical coverage; and intravenous-to-oral (i.v.-to-p.o.) switch between September 2009 and December 2012. Data were expressed as mean ± standard deviation for continuous variables, and unpaired Student’s t test was performed to determine intergroup differences between mean values. For categorical variables, data were presented as number and percentage and analyzed using the χ 2 test or Fisher’s exact test, as appropriate.

Results

ASP recommended 407 interventions with an overall acceptance rate of 66.8%. ASP interventions significantly reduced median duration of therapy by 2 [from a median (interquartile range, IQR) of 8 (6–12) days to 6 (4–9) days] and median length of stay by 5 days [from median (IQR) of 12 (5–32) days to 7 (3–18) days]. This led to an estimated total cost avoidance of USD 0.7 million. There were no significant differences in the 14-day reinfection, infection-related readmission and mortality rates between patients whose physicians accepted and those who rejected ASP interventions.

Conclusion

Interventions recommended by the ASP in Singapore General Hospital were safe and associated with a significant reduction in duration of therapy and hospital stay. The results of our study have affirmed the role of ASP in optimizing the care of patients with ABSSSI.
Literature
1.
go back to reference Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–406.CrossRefPubMed Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–406.CrossRefPubMed
2.
go back to reference Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother 2010; 65 Suppl 3: iii35–iii44. Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother 2010; 65 Suppl 3: iii35–iii44.
3.
go back to reference Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft tissue infections requiring hospitalization at an Academic Medical Center: opportunities for antimicrobial stewardship. Clin Infect Dis. 2010;51(8):895–903.CrossRefPubMed Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft tissue infections requiring hospitalization at an Academic Medical Center: opportunities for antimicrobial stewardship. Clin Infect Dis. 2010;51(8):895–903.CrossRefPubMed
4.
go back to reference Hatoum HT, Akhras KS, Lin SJ. The attributable clinical and economic burden of skin and soft tissue structure infections in hospitalized patients: a matched cohort study. Diagn Microbiol Infect Dis. 2009;64:305–10.CrossRefPubMed Hatoum HT, Akhras KS, Lin SJ. The attributable clinical and economic burden of skin and soft tissue structure infections in hospitalized patients: a matched cohort study. Diagn Microbiol Infect Dis. 2009;64:305–10.CrossRefPubMed
5.
go back to reference Liew YX, Lee W, Loh JCZ, et al. Impact of an antimicrobial stewardship programme on patient safety in Singapore General Hospital. Int J Antimicrob Agents. 2012;40:55–60.CrossRefPubMed Liew YX, Lee W, Loh JCZ, et al. Impact of an antimicrobial stewardship programme on patient safety in Singapore General Hospital. Int J Antimicrob Agents. 2012;40:55–60.CrossRefPubMed
6.
go back to reference Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.CrossRefPubMed Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.CrossRefPubMed
7.
go back to reference Hayashi Y, Paterson DL. Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Dis. 2011;52(10):1232–40.CrossRefPubMed Hayashi Y, Paterson DL. Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Dis. 2011;52(10):1232–40.CrossRefPubMed
8.
go back to reference Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.CrossRefPubMed Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.CrossRefPubMed
9.
go back to reference Antimicrobial Resistance Threats in the United States. U.S. Department of Health and Human Sciences, Centers for Disease Control and Prevention. 2013. Antimicrobial Resistance Threats in the United States. U.S. Department of Health and Human Sciences, Centers for Disease Control and Prevention. 2013.
10.
go back to reference Mertz D, Koller M, Haller P, et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother. 2009;64:188–99.PubMedCentralCrossRefPubMed Mertz D, Koller M, Haller P, et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother. 2009;64:188–99.PubMedCentralCrossRefPubMed
11.
go back to reference Drinka P, Bonham P, Crnich CJ. Swab culture of purulent skin infection to detect infection or colonization with antibiotic-resistant bacteria. JAMDA. 2012;13:75–9.PubMed Drinka P, Bonham P, Crnich CJ. Swab culture of purulent skin infection to detect infection or colonization with antibiotic-resistant bacteria. JAMDA. 2012;13:75–9.PubMed
Metadata
Title
Impact of Antimicrobial Stewardship Program (ASP) on Outcomes in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in an Acute-Tertiary Care Hospital
Authors
Li Wen Loo
Yi Xin Liew
Winnie Lee
Piotr Chlebicki
Andrea Lay-Hoon Kwa
Publication date
01-09-2015
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue Special Issue 1/2015
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-015-0085-7

Other articles of this Special Issue 1/2015

Infectious Diseases and Therapy 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.